accountfinal decision is expected by June 30. If approved the drug would be manufactured and marketed by partner King Pharmaceuticals, with Acura receiving royalty payments. Acura's chief science officer, Dr. Eric Carter, noted that the panel said the company's...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to New Painkiller-FDA Panel, 1st Ld-Writethru,0427
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account